$PPCB
Propanc Biopharma Inc Stock $ppcb

$ppcb Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-Q Financial Statement

#000114420416102344 Filed on May 16, 2016

Income Statement

Concept	2016 Q1	2015 Q1
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$780.0K	$510.0K
YoY Change	52.94%	410.0%
% of Gross Profit
Research & Development	$510.3K	$9.475K
YoY Change	5285.76%
% of Gross Profit
Depreciation & Amortization	$0.00	$0.00
YoY Change
% of Gross Profit
Operating Expenses	$1.291M	$516.6K
YoY Change	149.87%	395.2%
Operating Profit		-$516.6K
YoY Change		395.2%
Interest Expense	$1.104M	$199.3K
YoY Change	454.13%	901.39%
% of Operating Profit
Other Income/Expense, Net	-$861.1K	$62.32K
YoY Change	-1481.89%	66.4%
Pretax Income	-$2.152M	-$454.3K
YoY Change	373.72%	579.35%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.150M	-$454.3K
YoY Change	373.31%	579.35%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$526.6M	-$281.4M
COMMON SHARES
Basic Shares Outstanding	475.6M shares	191.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q1	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.480M	$170.0K
YoY Change	770.59%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets	$120.0K	$130.0K
YoY Change	-7.69%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$1.618M	$308.8K
YoY Change	423.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.678K	$808.00
YoY Change	355.2%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00
YoY Change
Total Long-Term Assets	$5.365K	$808.00
YoY Change	563.99%
TOTAL ASSETS
Total Short-Term Assets	$1.618M	$308.8K
Total Long-Term Assets	$5.365K	$808.00
Total Assets	$1.623M	$309.6K
YoY Change	424.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$159.3K	$291.0K
YoY Change	-45.26%	-11.81%
Accrued Expenses	$150.0K	$440.0K
YoY Change	-65.91%	2.33%
Deferred Revenue
YoY Change
Short-Term Debt	$1.060M	$1.250M
YoY Change	-15.2%	443.48%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.144M	$2.161M
YoY Change	138.08%	84.67%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.144M	$2.161M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$5.140M	$2.160M
YoY Change	137.96%	84.62%
SHAREHOLDERS EQUITY
Retained Earnings	-$27.52M	-$19.14M
YoY Change	43.78%
Common Stock	$602.5K	$332.8K
YoY Change	81.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.520M	-$1.851M
YoY Change
Total Liabilities & Shareholders Equity	$1.620M	$309.6K
YoY Change	423.22%

Cashflow Statement

Concept	2016 Q1	2015 Q1
OPERATING ACTIVITIES
Net Income	-$2.150M	-$454.3K
YoY Change	373.31%	579.35%
Depreciation, Depletion And Amortization	$0.00	$0.00
YoY Change
Cash From Operating Activities	-$720.0K	-$430.0K
YoY Change	67.44%	975.0%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.200M	580.0K
YoY Change	106.9%	1060.0%
NET CHANGE
Cash From Operating Activities	-720.0K	-430.0K
Cash From Investing Activities	0.000	0.000
Cash From Financing Activities	1.200M	580.0K
Net Change In Cash	480.0K	150.0K
YoY Change	220.0%	1400.0%
FREE CASH FLOW
Cash From Operating Activities	-$720.0K	-$430.0K
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$720.0K	-$430.0K
YoY Change	67.44%	975.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1794375	USD
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	236466	USD
CY2016Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	159323	USD
CY2015Q2	us-gaap	Assets Assets	627068	USD
CY2016Q1	us-gaap	Assets Assets	1623115	USD
CY2015Q2	us-gaap	Assets Current AssetsCurrent	621890	USD
CY2016Q1	us-gaap	Assets Current AssetsCurrent	1617750	USD
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	502616	USD
CY2016Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	117096	USD
CY2015Q2	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	11647	USD
CY2016Q1	us-gaap	Value Added Tax Receivable ValueAddedTaxReceivable	21628	USD
CY2016Q1	us-gaap	Notes Payable Current NotesPayableCurrent	2300	USD
CY2015Q2	us-gaap	Notes Payable Current NotesPayableCurrent	27558	USD
CY2015Q2	us-gaap	Cash Cash	107627	USD
CY2016Q1	us-gaap	Cash Cash	1479026	USD
CY2016Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	3659506	USD
CY2015Q2	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	780281	USD
CY2016Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	80630	USD
CY2015Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	269648	USD
CY2016Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	35168	USD
CY2015Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	35108	USD
CY2016Q1	ppch	Loans From Related Party LoansFromRelatedParty	56743	USD
CY2015Q2	ppch	Loans From Related Party LoansFromRelatedParty	79416	USD
CY2016Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	90602	USD
CY2015Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	71421	USD
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5143988	USD
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3680584	USD
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	602455	USD
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	347442	USD
CY2016Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23415658	USD
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20965671	USD
	us-gaap	Occupancy Costs OccupancyCosts	15062	USD
	us-gaap	Occupancy Costs OccupancyCosts	7710	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	510301	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9475	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	1290752	USD
	us-gaap	Operating Expenses OperatingExpenses	1004144	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-516565	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3441964	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1004144	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	1104315	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	199287	USD
	us-gaap	Interest Expense InterestExpense	2678604	USD
	us-gaap	Interest Expense InterestExpense	847942	USD
CY2016Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	USD
CY2015Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	13	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2027	USD
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3678	USD
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3494	USD
CY2015Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17458745	USD
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25445	USD
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	100968	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27518541	USD
CY2016Q1	us-gaap	Security Deposit SecurityDeposit	1687	USD
CY2015Q2	us-gaap	Security Deposit SecurityDeposit	1684	USD
CY2016Q1	us-gaap	Royalty Revenue RoyaltyRevenue	0	USD
CY2015Q1	us-gaap	Royalty Revenue RoyaltyRevenue	0	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	0	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	0	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	775216	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	504724	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2620324	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	980637	USD
CY2016Q1	us-gaap	Occupancy Costs OccupancyCosts	5235	USD
CY2015Q1	us-gaap	Occupancy Costs OccupancyCosts	2366	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	806578	USD
	us-gaap	Investment Income Interest InvestmentIncomeInterest	16	USD
CY2016Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	0	USD
CY2015Q1	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	0	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	0	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	50002	USD
CY2016Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	57118	USD
CY2015Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-42802	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-494772	USD
CY2016Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2015Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	331457	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-58893	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	366341	USD
CY2016Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	186070	USD
CY2015Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-27066	USD
CY2016Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-861127	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-598103	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	9961	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	5560	USD
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	246311	USD
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-20644	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-77543	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5322	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	19060	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	17531	USD
	ppch	Settlement Fees Paid In Form Of Debt SettlementFeesPaidInFormOfDebt	150000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	47366	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-77661	USD
	us-gaap	Depreciation Depreciation	507	USD
	us-gaap	Depreciation Depreciation	18	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2235257	USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	62315	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-2151879	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	167535	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	79940	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-914412	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-454250	USD
CY2016Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-238292	USD
CY2015Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	131659	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2390201	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-322591	USD
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	510808665	shares
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	201772426	shares
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	1359874	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	199727	USD
	ppch	Issuance Of Preferred Stock For Services IssuanceOfPreferredStockForServices	0	USD
	ppch	Issuance Of Preferred Stock For Services IssuanceOfPreferredStockForServices	1067	USD
	ppch	Settlement Fees Paid In Form Of Debt SettlementFeesPaidInFormOfDebt	0	USD
CY2015Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.60
CY2015Q4	ppch	Warrants Expire Period WarrantsExpirePeriod	P4Y
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-326341	USD
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	87818	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-27527	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	15041	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2205144	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-697541	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	676	USD
CY2014Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	25000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-676	USD
	us-gaap	Payments For Loans PaymentsForLoans	21491	USD
	us-gaap	Payments For Loans PaymentsForLoans	20000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	23843	USD
CY2015Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	352500	USD
CY2016Q1	ppch	Working Capital Deficit WorkingCapitalDeficit	3526238	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	4177500	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	675500	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	463976	USD
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	29000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3668190	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	684500	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-90971	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	94508	USD
	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	1371399	USD
	us-gaap	Cash Period Increase Decrease CashPeriodIncreaseDecrease	80549	USD
CY2014Q2	us-gaap	Cash Cash	87799	USD
CY2015Q1	us-gaap	Cash Cash	168348	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Interest Paid InterestPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	ppch	Prepaid Common Stock Issued For Services PrepaidCommonStockIssuedForServices	72757	USD
	ppch	Prepaid Common Stock Issued For Services PrepaidCommonStockIssuedForServices	134373	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	1034454	USD
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	37032	USD
	ppch	Conversion Of Convertible Notes And Accrued Interest To Common Stock ConversionOfConvertibleNotesAndAccruedInterestToCommonStock	3817285	USD
	ppch	Conversion Of Convertible Notes And Accrued Interest To Common Stock ConversionOfConvertibleNotesAndAccruedInterestToCommonStock	206940	USD
	ppch	Discounts Related To Warrants Issued With Convertible Debenture DiscountsRelatedToWarrantsIssuedWithConvertibleDebenture	1666635	USD
	ppch	Discounts Related To Warrants Issued With Convertible Debenture DiscountsRelatedToWarrantsIssuedWithConvertibleDebenture	0	USD
	ppch	Discounts Related To Lender Costs DiscountsRelatedToLenderCosts	0	USD
	ppch	Discounts Related To Lender Costs DiscountsRelatedToLenderCosts	48500	USD
	ppch	Discounts Related To Derivative Liability DiscountsRelatedToDerivativeLiability	2205925	USD
	ppch	Discounts Related To Derivative Liability DiscountsRelatedToDerivativeLiability	0	USD
	ppch	Conversion Of Loan Payable To Common Stock ConversionOfLoanPayableToCommonStock	0	USD
	ppch	Conversion Of Loan Payable To Common Stock ConversionOfLoanPayableToCommonStock	66389	USD
CY2014Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	250000	USD
CY2016Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	782500	USD
CY2015Q2	ppch	Debt Convertible Note Cash Purchase DebtConvertibleNoteCashPurchase	220000	USD
CY2015Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	20000	USD
CY2015Q2	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	1997	USD
CY2015Q2	ppch	Net Proceeds From Notes Issued NetProceedsFromNotesIssued	201997	USD
CY2015Q3	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	17690	USD
	ppch	Debt Discounts For Fees Paid DebtDiscountsForFeesPaid	4207500	USD
	ppch	Debt Discounts For Fees Paid DebtDiscountsForFeesPaid	166500	USD
CY2015Q4	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1500000	shares
CY2016Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	37569634	shares
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	15062	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	7710	USD
	ppch	Reimbursement On Goods And Service Tax Receivable Percentage ReimbursementOnGoodsAndServiceTaxReceivablePercentage	1	pure
CY2016Q1	us-gaap	Share Price SharePrice	0.0304
CY2016Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	3659506	USD
CY2016Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	80630	USD
CY2016Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	3740136	USD
	us-gaap	Gain Loss On Foreign Currency Fair Value Hedge Derivatives GainLossOnForeignCurrencyFairValueHedgeDerivatives	10490	USD
	ppch	Fair Value Of Warrant Derivative Liability Recoreded As Debt Discount FairValueOfWarrantDerivativeLiabilityRecorededAsDebtDiscount	2205925	USD
	ppch	Fair Value Of Warrant Derivative Liability Recoreded As Change In Fair Value Of Eco FairValueOfWarrantDerivativeLiabilityRecorededAsChangeInFairValueOfEco	2211529	USD
	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	-1716757	USD
CY2016Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	602454054	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	602454054	shares
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	347442013	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	347442013	shares
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	152285	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><u>Use of Estimates</u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;BACKGROUND-COLOR: transparent; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Significant estimates in the accompanying unaudited consolidated financial statements include the estimates of useful lives for depreciation, valuation of derivatives, valuation of beneficial conversion features on convertible debt, allowance for uncollectable receivables, valuation of equity based instruments issued for other than cash, the valuation allowance on deferred tax assets and foreign currency translation due to certain average exchange rates applied in lieu of spot rates on transaction dates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	300000000	shares
	us-gaap	Fair Value Assumptions Expected Dividend Rate FairValueAssumptionsExpectedDividendRate	0	pure
CY2015Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	782500	USD
CY2015Q2	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.55	pure
CY2015Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.07
	ppch	Warrants Term WarrantsTerm	P4Y
CY2016Q1	ppch	Receivable From Deposit Control Account Non Current ReceivableFromDepositControlAccountNonCurrent	1200000	USD
CY2016Q1	ppch	Receivable From Deposit Control Account Current ReceivableFromDepositControlAccountCurrent	375000	USD
CY2016Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.03
	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	0.225	pure
	ppch	Debt Instrument Maximum Conversion Percentage On Trading Volume DebtInstrumentMaximumConversionPercentageOnTradingVolume	0.25	pure
	us-gaap	Debt Instrument Increase Decrease Other Net DebtInstrumentIncreaseDecreaseOtherNet	50000	USD
CY2016Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	4350000	USD
CY2016Q1	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	4000000	USD
CY2016Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.045
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2015	ppch	Reimbursement On Goods And Service Tax Receivable Percentage ReimbursementOnGoodsAndServiceTaxReceivablePercentage	1	pure
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	21491	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	29744	AUD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	33000	AUD
	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	71500000	shares
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	2056059	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	4112118	USD
CY2015Q4	ppch	Warrants To Purchase Of Common Stock WarrantsToPurchaseOfCommonStock	26190476	USD

Files In Submission

Name	View Source	Status
0001144204-16-102344-index-headers.html	Edgar Link	pending
0001144204-16-102344-index.html	Edgar Link	pending
0001144204-16-102344.txt	Edgar Link	pending
0001144204-16-102344-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
ppch-20160331.xml	Edgar Link	completed
ppch-20160331.xsd	Edgar Link	pending
ppch-20160331_cal.xml	Edgar Link	unprocessable
ppch-20160331_def.xml	Edgar Link	unprocessable
ppch-20160331_lab.xml	Edgar Link	unprocessable
ppch-20160331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v439425_10q.htm	Edgar Link	pending
v439425_ex10-9.htm	Edgar Link	pending
v439425_ex31-1.htm	Edgar Link	pending
v439425_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PPCB
Propanc Biopharma Inc Stock $ppcb

2016 Q1 Form 10-Q Financial Statement

#000114420416102344 Filed on May 16, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PPCB Propanc Biopharma Inc Stock $ppcb

2016 Q1 Form 10-Q Financial Statement

#000114420416102344 Filed on May 16, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PPCB
Propanc Biopharma Inc Stock $ppcb